Intravenous sotalol for the termination of supraventricular tachycardia and atrial fibrillation and flutter: A multicenter, randomized, double-blind, placebo-controlled study
Ruey J. Sung(San Francisco General Hospital), S. Hardy(Bristol-Myers Squibb (United States)), Hanno L. Tan(Netherlands Heart Institute), Edward V. Platia(MedStar Washington Hospital Center), Rodney H. Falk(Brigham and Women's Hospital), Gopal D. Das(University of North Dakota), James Hanyok(Daiichi Sankyo (United States)), Labros A. Karagounis(University of Utah Hospital)
Cited by 121
Related Papers
Edoxaban versus Warfarin in Patients with Atrial Fibrillation
|New England Journal of Medicine|2013|5.2k
Nonbiopsy Diagnosis of Cardiac Transthyretin Amyloidosis
|Circulation|2016|2k
Definition of organ involvement and treatment response in immunoglobulin light chain amyloidosis (AL): A consensus opinion from the 10th International Symposium on Amyloid and Amyloidosis
|American Journal of Hematology|2005|1.4k
Long-Term Prognosis of Patients Diagnosed With Brugada Syndrome
|Circulation|2010|850
High-Dose Melphalan and Autologous Stem-Cell Transplantation in Patients with AL Amyloidosis: An 8-Year Study
|Annals of Internal Medicine|2004|615